Curtis Je
About
In The Last Decade
Curtis Je
12 papers receiving 370 citations
Peers
Comparison fields: 5 of 63
- Hematology 220
- Molecular Biology 167
- Oncology 88
- Immunology 78
- Public Health, Environmental and Occupational Health 68
Countries citing papers authored by Curtis Je
This map shows the geographic impact of Curtis Je's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Curtis Je with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Curtis Je more than expected).
Fields of papers citing papers by Curtis Je
This network shows the impact of papers produced by Curtis Je. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Curtis Je. The network helps show where Curtis Je may publish in the future.
Co-authorship network of co-authors of Curtis Je
This figure shows the co-authorship network connecting the top 25 collaborators of Curtis Je. A scholar is included among the top collaborators of Curtis Je based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Curtis Je. Curtis Je is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Response of the blast stem cells of acute myeloblastic leukemia to G-CSF, GM-CSF, or the ligand for C-KIT, alone or in combination. | 4 |
| 2 | Cytosine arabinoside (ara-C) and cis-dichlorodiammineplatinum II (cisplatin) alone and in combination: effects on acute myeloblastic leukemia blast cells in culture and in vivo. | 15 |
| 3 | Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate. | 34 |
| 4 | The expression of the proto-oncogene C-kit in the blast cells of acute myeloblastic leukemia. | 137 |
| 5 | Expression of a retinoic acid receptor gene in myeloid leukemia cells. | 89 |
| 6 | Interaction between retinoic acid and cytosine arabinoside affecting the blast cells of acute myeloblastic leukemia. | 39 |
| 7 | Heterogeneity in acute myeloblastic leukemia. | 19 |
| 8 | The combined use of cytosine arabinoside, cyclophosphamide, and total body irradiation as preparative regimen for bone marrow transplantation in patients with AML and CML. | 14 |
| 9 | Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma. | 23 |
| 10 | Efficacy of granulocyte transfusions collected from nonstimulated donors. | 3 |
| 11 | Remission maintenance of acute nonlymphoblastic leukemia with BCNU (NSC-409962) and cyclophosphamide (NSC-26271). | 10 |
| 12 | Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962). | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.